Adipose tissue engineering with preadipocyte-loaded scaffolds requires adequate tracking of preadipocytes to allow evaluation and quantification of cell proliferation, expansion and differentiation in three-dimensional systems. To differentiate between graft and host cells, labeling of preadipocytes before implantation and tracking of these cells until harvest would be useful. Immunohistochemistry enables the differentiation between cells of different species but is time-consuming, expensive, elaborate, and not applicable for autologous transplantation. So far, there is no published method to use externally applied dyes for tracking of human preadipocytes in adipose tissue engineering. We tested the cell dyes PKH26, CM-DiI, and CFSE to analyze their applicability for labeling human preadipocytes. CM-DiI had toxicity levels of 45–70%, while 3–4% proliferating cells were stained on day 35. CFSE revealed clear cytoplasmic coloring in proliferating cells with 5–6% stained cells after 35 days and toxicity ranging from 55 to 90% dead cells. PKH26 demonstrates lowest levels of toxicity and best labeling results after 4 weeks in proliferating preadipocytes in monolayer. Although none of the dyes showed long-lasting labeling during proliferation, all three dyes demonstrated permanent staining in differentiated cells. The results reveal the problems of preadipocyte tracking with fluorescent dyes but justify the dye application for limited time periods.

Keywords:
Adipose tissue engineering, Cellular tracking, Fluorescent dyes, Preadipocytes
1.
Andrade, W., T.J. Seabrook, M.G. Johnston, J.B. Hay (1996) The use of the lipophilic fluorochrome CM-DiI for tracking the migration of lymphocytes. J Immunol Methods 194: 181–189.
2.
Bereziat, V., S. Moritz, B. Klonjkowski, A. Decaudain, M. Auclair, M. Eloit, J. Capeau, C. Vigouroux (2005) Efficient adenoviral transduction of 3T3-F442A preadipocytes without affecting adipocyte differentiation. Biochimie 87: 951–958.
3.
Brandt, R., J. Leger, G. Lee (1995) Interaction of tau with the neural plasma membrane mediated by tau’s amino-terminal projection domain. J Cell Biol 131: 1327–1340.
4.
Finch, G.D., C.J. Dawe (2003) Hemiatrophy. J Pediatr Orthop 23: 99–101.
5.
Fokin, A.A., F. Robicsek (2002) Poland’s syndrome revisited. Ann Thorac Surg 74: 2218–2225.
6.
Hauner, H., G. Entenmann, M. Wabitsch, D. Gaillard, G. Ailhaud, R. Negrel, E.F. Pfeiffer, (1989) Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest 84: 1663–1670.
7.
Hauner, H., K. Rohrig, T. Petruschke (1995) Effects of epidermal growth factor (EGF), platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF) on human adipocyte development and function. Eur J Clin Invest 25: 90–96.
8.
Hauner, H., T. Shurk, M. Wabitsch (1998) Cultures of human adipose precursor cells; in Ailhaud G (ed): Methods in Molecular Biology. Totowa, Humana Press, vol 155, pp 239–247.
9.
Hemmrich, K., D. von Heimburg, K. Cierpka, S. Haydarlioglu, N. Pallua (2005a) Optimization of the differentiation of human preadipocytes in vitro. Differentiation 73: 28–35.
10.
Hemmrich, K., D. von Heimburg, R. Rendchen, C. Di Bartolo, E. Milella, N. Pallua (2005b) Implantation of preadipocyte-loaded hyaluronic acid-based scaffolds into nude mice to evaluate potential for soft tissue engineering. Biomaterials 26: 7025–7037.
11.
Hodgkin, P.D., J.H. Lee, A.B. Lyons (1996) B cell differentiation and isotype switching is related to division cycle number. J Exp Med 184: 277–281.
12.
Horan, P.K., M.J. Melnicoff, B.D. Jensen, S.E. Slezak (1990) Fluorescent cell labeling for in vivo and in vitro cell tracking. Methods Cell Biol 33: 469–490.
13.
Horan, P.K., S.E. Slezak (1989) Stable cell membrane labelling. Nature 340: 167–168.
14.
Hugo, P., J.W. Kappler, D.I. Godfrey, P.C. Marrack (1992) A cell line that can induce thymocyte positive selection. Nature 360: 679–682.
15.
Kawarasaki, T., G.R. Welch, C.R. Long, M. Yoshida, L.A. Johnson (1998) Verification of flow cytometrically-sorted X- and Y-bearing porcine spermatozoa and reanalysis of spermatozoa for DNA content using the fluorescence in situ hybridization (FISH) technique. Theriogenology 50: 625–635.
16.
Messina, L.M., R.M. Podrazik, T.A. Whitehill, D. Ekhterae, T.E. Brothers, J.M. Wilson, W.E. Burkel, J.C. Stanley (1992) Adhesion and incorporation of lacZ-transduced endothelial cells into the intact capillary wall in the rat. Proc Natl Acad Sci USA 89: 12018–12022.
17.
Nose, A., M. Takeichi (1986) A novel cadherin cell adhesion molecule: its expression patterns associated with implantation and organogenesis of mouse embryos. J Cell Biol 103: 2649–2658.
18.
Patrick, C., P. Chauvin, J. Hobley, G. Reece (1999) Preadipocyte seeded PLGA scaffolds for adipose tissue engineering. Tissue Engineering 5: 139–151.
19.
Patrick, C.W., Jr. (2001) Tissue engineering strategies for adipose tissue repair. Anat Rec 263: 361–366.
20.
Patrick, C.W., Jr., B. Zheng, C. Johnston, G.P. Reece (2002) Long-term implantation of preadipocyte-seeded PLGA scaffolds. Tissue Eng 8: 283–293.
21.
Peer, L. (1956) The neclected free fat graft. Am J Surg 18: 233–250.
22.
Rieck, B., S. Schlaak (2003) In vivo tracking of rat preadipocytes after autologous transplantation. Ann Plast Surg 51: 294–300.
23.
Roehm, N.W., G.H. Rodgers, S.M. Hatfield, A.L. Glasebrook (1991) An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods 142: 257–265.
24.
Rossatti, B. (1960) Revascularisation and phagocytosis in free fat autografts: an experimental study. Br J Plast Surg 13: 35–41.
25.
Samlowski, W.E., B.A. Robertson, B.K. Draper, E. Prystas, J.R. McGregor (1991) Effects of supravital fluorochromes used to analyze the in vivo homing of murine lymphocytes on cellular function. J Immunol Methods 144: 101–115.
26.
von Heimburg, D., K. Hemmrich, S. Haydarlioglu, H. Staiger, N. Pallua (2004) Comparison of viable cell yield from excised versus aspirated adipose tissue. Cells Tissues Organs 178: 87–92.
27.
von Heimburg, D., K. Hemmrich, S. Zachariah, H. Staiger, N. Pallua (2005) Oxygen consumption in undifferentiated versus differentiated adipogenic mesenchymal precursor cells. Respir Physiol Neurobiol 146: 107–116.
28.
von Heimburg, D., I. Heschel, S. Zachariah, H. Kühling, B. Hafemann, N. Pallua (2000) Human preadipocytes seeded on freeze-dried collagen scaffolds investigated in vitro and in vivo. Cells Tissues Organs 166: 69.
29.
von Heimburg, D., M. Kuberka, R. Rendchen, K. Hemmrich, G. Rau, N. Pallua (2003) Preadipocyte-loaded collagen scaffolds with enlarged pore size for improved soft tissue engineering. Int J Artif Organs 26: 1064–1076.
30.
von Heimburg, D., D. Ulrich, K. Hemmrich, N. Pallua (2001a) Soft tissue engineering by implantation of autologous adipose precursor cells into the rabbit ear – pathophysiology in adipose tissue transplantation. Clin Exp Plast Surg 33: 127–132.
31.
von Heimburg, D., S. Zachariah, A. Low, N. Pallua (2001b) Influence of different biodegradable carriers on the in vivo behavior of human adipose precursor cells. Plast Reconstr Surg 108: 411–420.
32.
Weston, S.A., C.R. Parish (1990) New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J Immunol Methods 133: 87–97.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.